Gene · 1723
Papers2,016
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,016
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Alterations in coenzyme Q10 status in a cybrid line harboring the 3243A>G mutation of mitochondrial DNA is associated with abnormal mitochondrial bioenergetics and dysregulated mitochondrial biogenesis. | Biochim Biophys Acta Bioenerg | 2024 | 38960080 | PubTator, text mining | PubMed |
| Targeted inhibition of DHODH is synergistic with BCL2 blockade in HGBCL with concurrent MYC and BCL2 rearrangement. | BMC Cancer | 2024 | 38918775 | PubTator, text mining | PubMed |
| Discovery of JNJ-74856665: A Novel Isoquinolinone DHODH Inhibitor for the Treatment of AML. | J Med Chem | 2024 | 38889244 | PubTator, text mining | PubMed |
| Synthesis and Characterization of DHODH Inhibitors Based on the Vidofludimus Scaffold with Pronounced Anti-SARS-CoV-2 Activity. | ChemMedChem | 2024 | 38887198 | PubTator, text mining | PubMed |
| A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma. | Redox Biol | 2024 | 38838551 | PubTator, text mining | PubMed |
| Understanding the Antiplasmodial Action of Resistance-Refractory Xanthoquinodin A1. | ACS Infect Dis | 2024 | 38810215 | PubTator, text mining | PubMed |
| Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. | Redox Biol | 2024 | 38805974 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental verification of the cancer-promoting effect of DHODH in clear cell renal cell carcinoma. | Sci Rep | 2024 | 38796629 | PubTator, text mining | PubMed |
| Classical swine fever virus non-structural protein 4A recruits dihydroorotate dehydrogenase to facilitate viral replication. | J Virol | 2024 | 38757985 | PubTator, text mining | PubMed |
| Blocking SLC7A11 attenuates the proliferation of esophageal squamous cell carcinoma cells. | Anim Cells Syst (Seoul) | 2024 | 38741950 | PubTator, text mining | PubMed |
| Structural and Functional Analyses of Inhibition of Human Dihydroorotate Dehydrogenase by Antiviral Furocoumavirin. | Biochemistry | 2024 | 38724483 | PubTator, text mining | PubMed |
| Corrigendum to "Menaquinone-4 attenuates ferroptosis by upregulating DHODH through activation of SIRT1 after subarachnoid hemorrhage" [Free Radic. Biol. Med. 210 (2024) 416-429]. | Free Radic Biol Med | 2024 | 38677202 | PubTator, text mining | PubMed |
| POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase. | Cell Death Dis | 2024 | 38575587 | PubTator, text mining | PubMed |
| Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia. | Eur J Haematol | 2024 | 38558052 | PubTator, text mining | PubMed |
| Safety and Tolerability of KIO-101 Eye Drops in Healthy Volunteers and Patients with Ocular Surface Disease-A Phase I Study. | Pharmaceutics | 2024 | 38543260 | PubTator, text mining | PubMed |
| Discovery of Alternative Binding Poses through Fragment-Based Identification of DHODH Inhibitors. | ACS Med Chem Lett | 2024 | 38505861 | PubTator, text mining | PubMed |
| Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence. | Mol Psychiatry | 2024 | 38499654 | PubTator, text mining | PubMed |
| DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer. | Oncogene | 2024 | 38480915 | PubTator, text mining | PubMed |
| Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems. | ACS Nano | 2024 | 38452275 | PubTator, text mining | PubMed |
| Retinoblastoma vulnerability to combined de novo and salvage pyrimidine ribonucleotide synthesis pharmacologic blockage. | Heliyon | 2024 | 38332874 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1723/papers?page=12